Erratum: 2010 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines (Journal of the American College of Cardiology (2013) 61 (485-510) DOI:10.1016/j.jacc.2012.11.018);2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: Executive summary: A report of the American college of cardiology foundation/american heart association task force on practice guidelines

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 485-510

  O'Gara, Patrick T ^a   Kushner, Frederick G ^a   Ascheim, Deborah D ^a   Casey, Donald E ^a   Chung, Mina K ^a   De Lemos, James A ^a   Ettinger, Steven M ^a   Fang, James C ^a   Fesmire, Francis M ^a   Franklin, Barry A ^a   Granger, Christopher B ^a   Krumholz, Harlan M ^a   Linderbaum, Jane A ^a   Morrow, David A ^a   Newby, L Kristin ^a   Ornato, Joseph P ^a   Ou, Narith ^a   Radford, Martha J ^a   Tamis Holland, Jacqueline E ^a   Tommaso, Carl L ^a   Tracy, Cynthia M ^a   Woo, Y Joseph ^a   Zhao, David X ^a   more..

^a NONE

Author keywords

ACCF AHA Practice Guidelines; anticoagulants; antiplatelets; door to balloon; fibrinolysis; percutaneous coronary intervention; reperfusion; ST elevation myocardial infarction

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PACING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL SOCIETY; NON INVASIVE MEASUREMENT; OUT OF HOSPITAL CARDIAC ARREST; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PERICARDITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; THERAPY DELAY; THROMBUS ASPIRATION; TREATMENT INDICATION;

EID: 84872710874     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.008     Document Type: Erratum

References (232)

1. ACCF/AHA Task Force on Practice Guidelines Manual for ACCF/AHA Guideline Writing Committees: Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines American College of Cardiology and American Heart Association 2006 http://my.americanheart.org/professional/StatementsGuidelines/ PoliciesDevelopment/Development/Methodologies-and-Policies-from-the-CCAHA-Task- Force-on-Practice-Guidelines-UCM-320470-Article.jsp http://assets.cardiosource. com/Methodology-Manual-for-ACC-AHA-Writing-Committees.pdf Accessed July 26, 2012
2. J. Eden, L. Levit, A. Berg Committee on Standards for Systematic Reviews of Comparative Effectiveness Research; Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews 2011 The National Academies Press Washington, DC
3. R. Graham, M. Mancher, D. Miller Wolman Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine. Clinical Practice Guidelines We Can Trust 2011 The National Academies Press Washington, DC
4. P.T. O'Gara, F.G. Kushner, D.D. Ascheim 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 2012 Dec 17 10.1016/j.jacc.2012.11.019 [E-pub ahead of print]
5. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 e1 e212
6. E.M. Antman, M. Hand, P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
7. F.G. Kushner, M. Hand, S.C. Smith Jr 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241 Erratum in: J Am Coll Cardiol 54 2010 2464
8. F.V. Aguirre, J.J. Varghese, M.P. Kelley Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program Circulation 117 2008 1145 1152
9. T.D. Henry, S.W. Sharkey, M.N. Burke A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction Circulation 116 2007 721 728
10. J.G. Jollis, M.L. Roettig, A.O. Aluko Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction JAMA 298 2007 2371 2380
11. M.R. Le May, D.Y. So, R. Dionne A citywide protocol for primary PCI in ST-segment elevation myocardial infarction N Engl J Med 358 2008 231 240
12. H.-J. Dieker, S.S.B. Liem, H. El Aidi Pre-hospital triage for primary angioplasty: direct referral to the intervention center versus interhospital transport J Am Coll Cardiol Intv 3 2010 705 711
13. D.B. Diercks, M.C. Kontos, A.Y. Chen Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry J Am Coll Cardiol 53 2009 161 166
14. I.C. Rokos, W.J. French, W.J. Koenig Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on door-to-balloon times across 10 independent regions J Am Coll Cardiol Intv 2 2009 339 346
15. J.T. Sørensen, C.J. Terkelsen, B.L. Nørgaard Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction Eur Heart J 32 2011 430 436
16. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Lancet 343 1994 311 322 Erratum in: Lancet 343 1994 742
17. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
18. H.R. Andersen, T.T. Nielsen, T. Vesterlund Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2) Am Heart J 146 2003 234 241
19. M. Dalby, A. Bouzamondo, P. Lechat Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis Circulation 108 2003 1809 1814
20. H.R. Andersen, T.T. Nielsen, K. Rasmussen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
21. P.H. Nielsen, C.J. Terkelsen, T.T. Nielsen System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial) Am J Cardiol 108 2011 776 781
22. B.K. Nallamothu, E.R. Bates Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92 2003 824 826
23. D.S. Pinto, A.J. Kirtane, B.K. Nallamothu Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation 114 2006 2019 2025
24. E. Boersma, A.C. Maas, J.W. Deckers Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775
25. P. Chareonthaitawee, R.J. Gibbons, R.S. Roberts CORE Investigators (Collaborative Organisation for RheothRx Evaluation) The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction Heart 84 2000 142 148
26. R.L. McNamara, J. Herrin, Y. Wang Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction Am J Cardiol 100 2007 1227 1232
27. J.J. Milavetz, D.W. Giebel, T.F. Christian Time to therapy and salvage in myocardial infarction J Am Coll Cardiol 31 1998 1246 1251
28. L.K. Newby, W.R. Rutsch, R.M. Califf GUSTO-1 Investigators Time from symptom onset to treatment and outcomes after thrombolytic therapy J Am Coll Cardiol 27 1996 1646 1655
29. A. Schömig, J. Mehilli, D. Antoniucci Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial JAMA 293 2005 2865 2872
30. M. Gierlotka, M. Gasior, K. Wilczek Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]) Am J Cardiol 107 2011 501 508
31. M.A. Peberdy, C.W. Callaway, R.W. Neumar Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 122 2010 S768 S786 Errata in: Circulation 124 2011 e403 Circulation 123 2011 e237
32. S.A. Bernard, T.W. Gray, M.D. Buist Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia N Engl J Med 346 2002 557 563
33. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 346 2002 549 556 Erratum in: N Engl J Med 346 2002 1756
34. G. Nichol, T.P. Aufderheide, B. Eigel Regional systems of care for out-of-hospital cardiac arrest: a policy statement from the American Heart Association Circulation 121 2010 709 729 Erratum in: Circulation 122 2010 e439
35. B. Bendz, J. Eritsland, A.R. Nakstad Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention Resuscitation 63 2004 49 53
36. A.E. Borger van der Burg, J.J. Bax, E. Boersma Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital Am J Cardiol 91 2003 785 789
37. S. Bulut, W.R. Aengevaeren, H.J. Luijten Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? Resuscitation 47 2000 155 161
38. P. Garot, T. Lefevre, H. Eltchaninoff Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction Circulation 115 2007 1354 1362
39. V. Gorjup, P. Radsel, S.T. Kocjancic Acute ST-elevation myocardial infarction after successful cardiopulmonary resuscitation Resuscitation 72 2007 379 385
40. V.R. Hosmane, N.G. Mustafa, V.K. Reddy Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest J Am Coll Cardiol 53 2009 409 415
41. J.K. Kahn, S. Glazier, R. Swor Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest Am J Cardiol 75 1995 1069 1070
42. P.C. Keelan, T.J. Bunch, R.D. White Early direct coronary angioplasty in survivors of out-of-hospital cardiac arrest Am J Cardiol 91 2003 1461 1463 A6
43. K.B. Kern, O. Rahman Emergent percutaneous coronary intervention for resuscitated victims of out-of-hospital cardiac arrest Catheter Cardiovasc Interv 75 2010 616 624
44. E. Marcusohn, E. Markusohn, A. Roguin Primary percutaneous coronary intervention after out-of-hospital cardiac arrest: patients and outcomes Isr Med Assoc J 9 2007 257 259
45. M. Pleskot, A. Babu, R. Hazukova Out-of-hospital cardiac arrests in patients with acute ST elevation myocardial infarctions in the East Bohemian region over the period 2002-2004 Cardiology 109 2008 41 51
46. B. Quintero-Moran, R. Moreno, S. Villarreal Percutaneous coronary intervention for cardiac arrest secondary to ST-elevation acute myocardial infarction: influence of immediate paramedical/medical assistance on clinical outcome J Invasive Cardiol 18 2006 269 272
47. N. Richling, H. Herkner, M. Holzer Thrombolytic therapy vs primary percutaneous intervention after ventricular fibrillation cardiac arrest due to acute ST-segment elevation myocardial infarction and its effect on outcome Am J Emerg Med 25 2007 545 550
48. C.M. Spaulding, L.M. Joly, A. Rosenberg Immediate coronary angiography in survivors of out-of-hospital cardiac arrest N Engl J Med 336 1997 1629 1633
49. M. Werling, A.-B. Thorén, C. Axelsson Treatment and outcome in post-resuscitation care after out-of-hospital cardiac arrest when a modern therapeutic approach was introduced Resuscitation 73 2007 40 45
50. F. Zijlstra, J.C. Hoorntje, M.J. de Boer Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419
51. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction N Engl J Med 336 1997 1621 1628 Erratum in: N Engl J Med 337 1997 287
52. M. Grzybowski, E.A. Clements, L. Parsons Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis JAMA 290 2003 1891 1898
53. R. Zahn, S. Schuster, R. Schiele Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy Catheter Cardiovasc Interv 46 1999 127 133
54. J.S. Hochman, L.A. Sleeper, J.G. Webb SHOCK Investigators Early revascularization in acute myocardial infarction complicated by cardiogenic shock N Engl J Med 341 1999 625 634
55. J.S. Hochman, G.A. Lamas, C.E. Buller Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 355 2006 2395 2407
56. J.J. Thune, D.E. Hoefsten, M.G. Lindholm Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty Circulation 112 2005 2017 2021
57. A.H. Wu, L. Parsons, N.R. Every Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 2002 1389 1394
58. E.L. Hannan, Z. Samadashvili, G. Walford Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease J Am Coll Cardiol Intv 3 2010 22 31
59. M. Toma, C.E. Buller, C.M. Westerhout Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial Eur Heart J 31 2010 1701 1707
60. P.J. Vlaar, K.D. Mahmoud, D.R. Holmes Jr Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis J Am Coll Cardiol 58 2011 692 703
61. A.A. Bavry, D.J. Kumbhani, D.L. Bhatt Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials Eur Heart J 29 2008 2989 3001
62. P.J. Vlaar, T. Svilaas, I.C. van der Horst Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920
63. G. Sardella, M. Mancone, C. Bucciarelli-Ducci Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (Thrombectomy With Export Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention) prospective, randomized trial J Am Coll Cardiol 53 2009 309 315
64. G.W. Stone, A. Maehara, B. Witzenbichler Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
65. A.J. Nordmann, P. Hengstler, T. Harr Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials Am J Med 116 2004 253 262
66. M.M. Zhu, A. Feit, H. Chadow Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials Am J Cardiol 88 2001 297 301
67. J.A. Spertus, R. Kettelkamp, C. Vance Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
68. G.L. Kałuza, J. Joseph, J.R. Lee Catastrophic outcomes of noncardiac surgery soon after coronary stenting J Am Coll Cardiol 35 2000 1288 1294
69. C.L. Grines, R.O. Bonow, D.E. Casey Jr Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians Circulation 115 2007 813 818
70. D.-W. Park, S.-W. Park, K.-H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
71. A. Jeremias, B. Sylvia, J. Bridges Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 2004 1930 1932
72. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
73. M. Nasser, M. Kapeliovich, W. Markiewicz Late thrombosis of sirolimus-eluting stents following noncardiac surgery Catheter Cardiovasc Interv 65 2005 516 519
74. S.S. Jolly, J. Pogue, K. Haladyn Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study Eur Heart J 30 2009 900 907
75. E.S. Barnathan, J.S. Schwartz, L. Taylor Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty Circulation 76 1987 125 134
76. S.R. Mehta, J.-P. Bassand, S. Chrolavicius Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 2010 930 942 Erratum in: N Engl J Med 363 2010 1585
77. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86 Erratum in: BMJ 324 2002 141
78. A. Schömig, F.J. Neumann, A. Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089
79. Deleted in press.
80. S.C. Smith Jr, E.J. Benjamin, R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
81. G. Patti, G. Bárczi, D. Orlic Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study J Am Coll Cardiol 58 2011 1592 1599
82. S.R. Mehta, J.-F. Tanguay, J.W. Eikelboom Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
83. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
84. P.G. Steg, S. James, R.A. Harrington Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
85. G. Montalescot, S.D. Wiviott, E. Braunwald Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
86. V.L. Serebruany, S.R. Steinhubl, P.B. Berger Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials Am J Cardiol 95 2005 1218 1222
87. S.R. Steinhubl, D.L. Bhatt, D.M. Brennan Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding Ann Intern Med 150 2009 379 386
88. S.J. Brener, L.A. Barr, J.E. Burchenal ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction Circulation 98 1998 734 741
89. G.W. Stone, C.L. Grines, D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
90. G. Montalescot, P. Barragan, O. Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
91. J.M. ten Berg, A.W.J. van't Hof, T. Dill Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome J Am Coll Cardiol 55 2010 2446 2455
92. M. Valgimigli, G. Campo, G. Percoco Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799
93. A. Akerblom, S.K. James, M. Koutouzis Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) J Am Coll Cardiol 56 2010 470 475
94. S.G. Ellis, P. Armstrong, A. Betriu Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial Am Heart J 147 2004 E16
95. S.G. Ellis, M. Tendera, M.A. de Belder 1-Year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial J Am Coll Cardiol Intv 2 2009 909 916
96. G. Montalescot, M. Borentain, L. Payot Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis JAMA 292 2004 362 366
97. M. Maioli, F. Bellandi, M. Leoncini Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial) J Am Coll Cardiol 49 2007 1517 1524
98. E.C. Keeley, J.A. Boura, C.L. Grines Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials Lancet 367 2006 579 588 Erratum in: Lancet 367 2006 1656
99. A.W.J. van't Hof, J. Ten Berg, T. Heestermans Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
100. C. El Khoury, P.-Y. Dubien, C. Mercier Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention: the AGIR-2 study Arch Cardiovasc Dis 103 2010 285 292
101. G. De Luca, F. Bellandi, K. Huber Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis J Thromb Haemost 9 2011 2361 2370
102. J. Mehilli, A. Kastrati, S. Schulz Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
103. F. Bellandi, M. Maioli, M. Gallopin Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention Catheter Cardiovasc Interv 62 2004 186 192
104. E. Romagnoli, F. Burzotta, C. Trani Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI Int J Cardiol 105 2005 250 255
105. A. Iversen, S. Galatius, J.S. Jensen The optimal route of administration of the glycoprotein IIb/IIIa receptor antagonist abciximab during percutaneous coronary intervention: intravenous versus intracoronary Curr Cardiol Rev 4 2008 293 299
106. A.K. Kakkar, A. Moustapha, H.G. Hanley Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting Catheter Cardiovasc Interv 61 2004 31 34
107. J. Wöhrle, O.C. Grebe, T. Nusser Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty Circulation 107 2003 1840 1843
108. O.F. Bertrand, J. Rodés-Cabau, E. Larose Intracoronary compared to intravenous abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study Am J Cardiol 105 2010 1520 1527
109. G.W. Stone, B. Witzenbichler, G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
110. S. Yusuf, S.R. Mehta, S. Chrolavicius Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA 295 2006 1519 1530
111. AIMS Trial Study Group Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial Lancet 1 1988 545 549
112. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction Lancet 342 1993 767 772
113. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
114. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction Lancet 342 1993 759 766
115. P. Rossi, L. Bolognese Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction: Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group Am J Cardiol 68 1991 585 592
116. The I.S.A.M. Study Group A prospective trial of Intravenous Streptokinase in Acute Myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days N Engl J Med 314 1986 1465 1471
117. R.J. de Winter, N.J.W. Verouden, H.J.J. Wellens A new ECG sign of proximal LAD occlusion N Engl J Med 359 2008 2071 2073
118. The TIMI IIIA Investigators Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial Circulation 87 1993 38 52
119. J.A. Barrabés, J. Figueras, C. Moure Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction Circulation 108 2003 814 819
120. G.-P. Jong, T. Ma, P. Chou Reciprocal changes in 12-lead electrocardiography can predict left main coronary artery lesion in patients with acute myocardial infarction Int Heart J 47 2006 13 20
121. Z.M. Chen, L.X. Jiang, Y.P. Chen Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
122. M.S. Sabatine, C.P. Cannon, C.M. Gibson Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
123. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
124. E.M. Antman, D.A. Morrow, C.H. McCabe Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med 354 2006 1477 1488
125. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
126. A.M. Ross, P. Molhoek, C. Lundergan Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II) Circulation 104 2001 648 652
127. E.M. Antman, H.W. Louwerenburg, H.F. Baars Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation 105 2002 1642 1649 Erratum in: Circulation 105 2002 2799
128. J.S. Hochman, L.A. Sleeper, H.D. White One-year survival following early revascularization for cardiogenic shock JAMA 285 2001 190 192
129. A.H. Gershlick, A. Stephens-Lloyd, S. Hughes Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction N Engl J Med 353 2005 2758 2768
130. A.G.C. Sutton, P.G. Campbell, R. Graham A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial J Am Coll Cardiol 44 2004 287 296
131. C.M. Gibson, S.A. Murphy, M.J. Rizzo Thrombolysis In Myocardial Infarction (TIMI) Study Group Relationship between TIMI frame count and clinical outcomes after thrombolytic administration Circulation 99 1999 1945 1950
132. C.M. Gibson, C.P. Cannon, S.A. Murphy Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 2002 1909 1913
133. A.G. Sutton, P.G. Campbell, D.J. Price Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method Heart 84 2000 149 156
134. H.C. Wijeysundera, R. Vijayaraghavan, B.K. Nallamothu Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials J Am Coll Cardiol 49 2007 422 430
135. J.-P. Collet, G. Montalescot, M. Le May Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy J Am Coll Cardiol 48 2006 1326 1335
136. E. Bøhmer, P. Hoffmann, M. Abdelnoor Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction) J Am Coll Cardiol 55 2010 102 110
137. F. Borgia, S.G. Goodman, S. Halvorsen Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis Eur Heart J 31 2010 2156 2169
138. W.J. Cantor, D. Fitchett, B. Borgundvaag Routine early angioplasty after fibrinolysis for acute myocardial infarction N Engl J Med 360 2009 2705 2718
139. C. Di Mario, D. Dudek, F. Piscione Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial Lancet 371 2008 559 568
140. F. Fernandez-Avilés, J.J. Alonso, A. Castro-Beiras Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial Lancet 364 2004 1045 1053
141. H.D. White Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis Circulation 118 2008 219 222
142. P.G. Steg, A. Kerner, F. Van de Werf Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure Circulation 118 2008 1163 1171
143. P.G. Steg, O.H. Dabbous, L.J. Feldman Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 2004 494 499
144. P. Erne, A.W. Schoenenberger, D. Burckhardt Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial JAMA 297 2007 1985 1991
145. J.K. Madsen, P. Grande, K. Saunamäki Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI): DANish trial in Acute Myocardial Infarction Circulation 96 1997 748 755
146. S.P. D'Souza, M.A. Mamas, D.G. Fraser Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis Eur Heart J 32 2011 972 982
147. M. Gupta, W.-C. Chang, F. Van de Werf International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2 Eur Heart J 24 2003 1640 1650
148. C.M. Gibson, J. Karha, S.A. Murphy Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis In Myocardial Infarction trials J Am Coll Cardiol 42 2003 7 16
149. J.P.A. Ioannidis, D.G. Katritsis Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients Am Heart J 154 2007 1065 1071
150. P.G. Steg, C. Thuaire, D. Himbert DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction Eur Heart J 25 2004 2187 2194
151. S.H. Wilson, M.R. Bell, C.S. Rihal Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction Am Heart J 141 2001 704 710
152. C.M. Gibson, S.A. Murphy, G. Montalescot Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol 49 2007 2238 2246
153. E.A. Caracciolo, K.B. Davis, G. Sopko Comparison of surgical and medical group survival in patients with left main coronary artery disease: long-term CASS experience Circulation 91 1995 2325 2334
154. J.S. Hochman, C.E. Buller, L.A. Sleeper Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 2000 1063 1070
155. L.D. Hillis, P.K. Smith, J.L. Anderson 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e123 e210
156. M.J. Dalrymple-Hay, S.M. Langley, S.A. Sami Should coronary artery bypass grafting be performed at the same time as repair of a post-infarct ventricular septal defect? Eur J Cardiothorac Surg 13 1998 286 292
157. V. Menon, J.G. Webb, L.D. Hillis Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36 2000 1110 1116
158. J. Slater, R.J. Brown, T.A. Antonelli Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry: Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36 2000 1117 1122
159. R. Tavakoli, A. Weber, P. Vogt Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture J Heart Valve Dis 11 2002 20 25 discussion 26
160. C.R. Thompson, C.E. Buller, L.A. Sleeper Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36 2000 1104 1109
161. M. Jacob, N. Smedira, E. Blackstone Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery Circulation 123 2011 577 583
162. J.H.-J. Kim, L.K. Newby, R.M. Clare Clopidogrel use and bleeding after coronary artery bypass graft surgery Am Heart J 156 2008 886 892
163. C. Held, N. Asenblad, J.P. Bassand Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial J Am Coll Cardiol 57 2011 672 684
164. S.S. Nijjer, G. Watson, T. Athanasiou Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies Eur Heart J 32 2011 2970 2988
165. C.M. Barker, H.V. Anderson Acute coronary syndromes: don't bypass the clopidogrel J Am Coll Cardiol 53 2009 1973 1974
166. R. Ebrahimi, C. Dyke, R. Mehran Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
167. F. Bizzarri, S. Scolletta, E. Tucci Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting J Thorac Cardiovasc Surg 122 2001 1181 1185
168. C.M. Dyke, D. Bhatia, T.J. Lorenz Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT: Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy Ann Thorac Surg 70 2000 866 871 discussion 871-2
169. J.K. Shim, Y.S. Choi, Y.J. Oh Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 2007 59 64
170. Y.J. Woo, T. Grand, N. Valettas Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration Heart Surg Forum 6 2003 282 285
171. S. Maltais, L.P. Perrault, Q.-B. Do Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery Eur J Cardiothorac Surg 34 2008 127 131
172. Z.M. Chen, H.C. Pan, Y.P. Chen Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
173. R. Roberts, W.J. Rogers, H.S. Mueller Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
174. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
175. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results JAMA 247 1982 1707 1714
176. N. Freemantle, J. Cleland, P. Young beta Blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
177. M.A. Pfeffer, E. Braunwald, L.A. Moyé SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669 677
178. S.G. Ball, A.S. Hall, G.D. Murray ACE inhibition, atherosclerosis and myocardial infarction: the AIRE Study in practice: Acute Infarction Ramipril Efficacy Study Eur Heart J 15 Suppl B 1994 20 25 discussion 26-30
179. L. Køber, C. Torp-Pedersen, J.E. Carlsen Trandolapril Cardiac Evaluation (TRACE) Study Group A clinical trial of the angiotensin-converting- enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670 1676
180. M.A. Pfeffer, S.C. Greaves, J.M. Arnold Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: the Healing and Early Afterload Reducing Therapy trial Circulation 95 1997 2643 2651
181. M.A. Pfeffer, J.J.V. McMurray, E.J. Velazquez Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906 Erratum in: N Engl J Med 350 2004 203
182. A.P. Maggioni, G. Fabbri VALIANT (VALsartan In Acute myocardial iNfarcTion) trial Expert Opin Pharmacother 6 2005 507 512
183. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 Erratum in: N Engl J Med 348 2003 2271
184. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials Circulation 97 1998 2202 2212
185. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
186. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
187. C.P. Cannon, B.A. Steinberg, S.A. Murphy Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol 48 2006 438 445
188. Deleted in press.
189. Deleted in press.
190. Deleted in press.
191. C. Baigent, L. Blackwell, J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
192. C.P. Cannon, E. Braunwald, C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 Erratum in: N Engl J Med 354 2006 778
193. A. Babaev, P.D. Frederick, D.J. Pasta Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock JAMA 294 2005 448 454
194. J.S. Hochman, L.A. Sleeper, J.G. Webb Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction JAMA 295 2006 2511 2515
195. D.A. Morrow, E.M. Antman, A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
196. J.K. French, H.A. Feldman, S.F. Assmann Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial Am Heart J 146 2003 804 810
197. H.V. Barron, N.R. Every, L.S. Parsons The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2 Am Heart J 141 2001 933 939
198. E.W. Chen, J.G. Canto, L.S. Parsons Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock Circulation 108 2003 951 957
199. T.A. Sanborn, L.A. Sleeper, E.R. Bates Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 2000 1123 1129
200. K.D. Sjauw, A.E. Engström, M.M. Vis A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30 2009 459 468
201. E.M. Ohman, J. Nanas, R.J. Stomel Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial J Thromb Thrombolysis 19 2005 33 39
202. E.F. Wever, R.N. Hauer, F.L. van Capelle Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors Circulation 91 1995 2195 2203
203. J. Siebels, K.H. Kuck Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg) Am Heart J 127 1994 1139 1144
204. S.J. Connolly, A.P. Hallstrom, R. Cappato AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator study: Cardiac Arrest Study Hamburg: Canadian Implantable Defibrillator Study Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials Eur Heart J 21 2000 2071 2078
205. J. Berman, C.I. Haffajee, J.S. Alpert Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution Am Heart J 101 1981 750 753
206. B.H. Bulkley, W.C. Roberts Steroid therapy during acute myocardial infarction: a cause of delayed healing and of ventricular aneurysm Am J Med 56 1974 244 250
207. H.S. Silverman, M.P. Pfeifer Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction Am J Cardiol 59 1987 363 364
208. F. Andreotti, L. Testa, G.G.L. Biondi-Zoccai Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients Eur Heart J 27 2006 519 526
209. J.J. You, D.E. Singer, P.A. Howard Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
210. P.O. Vandvik, A.M. Lincoff, J.M. Gore Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e637S e668S Erratum in: Chest 141 2012 1129
211. G.Y.H. Lip, K. Huber, F. Andreotti Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary: a Consensus Document of the European Society of Cardiology Working Group on Thrombosis Eur Heart J 31 2010 1311 1318
212. D.P. Faxon, J.W. Eikelboom, P.B. Berger Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North-American perspective Thromb Haemost 106 2011 572 584
213. P. Théroux, D.D. Waters, C. Halphen Prognostic value of exercise testing soon after myocardial infarction N Engl J Med 301 1979 341 345
214. A. Villella, A.P. Maggioni, M. Villella Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base: Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto Lancet 346 1995 523 529
215. J.A. Leppo, J. O'Brien, J.A. Rothendler Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction N Engl J Med 310 1984 1014 1018
216. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
217. S.H. Hohnloser, K.H. Kuck, P. Dorian Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
218. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62 Erratum in: J Am Coll Cardiol 53 2009 147
219. G. Steinbeck, D. Andresen, K. Seidl Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
220. M. Naylor, D. Brooten, R. Jones Comprehensive discharge planning for the hospitalized elderly: a randomized clinical trial Ann Intern Med 120 1994 999 1006
221. E.A. Coleman, C. Parry, S. Chalmers The care transitions intervention: results of a randomized controlled trial Arch Intern Med 166 2006 1822 1828
222. W. Young, G. Rewa, S.G. Goodman Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial CMAJ 169 2003 905 910
223. B.W. Jack, V.K. Chetty, D. Anthony A reengineered hospital discharge program to decrease rehospitalization: a randomized trial Ann Intern Med 150 2009 178 187
224. J.M. Lappé, J.B. Muhlestein, D.L. Lappé Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program Ann Intern Med 141 2004 446 453
225. A.S. Leon, B.A. Franklin, F. Costa Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation 111 2005 369 376 Erratum in: Circulation 111 2005 1717
226. J.A. Suaya, W.B. Stason, P.A. Ades Cardiac rehabilitation and survival in older coronary patients J Am Coll Cardiol 54 2009 25 33
227. R.S. Taylor, A. Brown, S. Ebrahim Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials Am J Med 116 2004 682 692
228. K. Goel, R.J. Lennon, R.T. Tilbury Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community Circulation 123 2011 2344 2352
229. K. Wilson, N. Gibson, A. Willan Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies Arch Intern Med 160 2000 939 944
230. C.C. Thomson, N.A. Rigotti Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease Prog Cardiovasc Dis 45 2003 459 479
231. N. Dawood, V. Vaccarino, K.J. Reid Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success Arch Intern Med 168 2008 1961 1967
232. A.M. Shah, M.A. Pfeffer, L.H. Hartley Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction Am J Cardiol 106 2010 911 916